PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24926821-2	2014	The majority of human PCas express a transmembrane protease serine 2 (TMPRSS2):erythroblast transformation-specific (ETS) fusion gene, but most preclinical studies have been performed in PCa models lacking TMPRSS2:ETS in part due to the limited availability of model systems expressing endogenous TMPRSS2:ETS.	ets	214-217	transmembrane serine protease 2	Homo sapiens	70-77	
24926821-10	2014	Our findings suggest that patients with TMPRSS2:ETS negative tumors may be more responsive to VDR-mediated growth inhibition and that TMPRSS2:ETS status should be considered in future clinical trials.	ets	48-51	transmembrane serine protease 2	Homo sapiens	40-47	
24926821-10	2014	Our findings suggest that patients with TMPRSS2:ETS negative tumors may be more responsive to VDR-mediated growth inhibition and that TMPRSS2:ETS status should be considered in future clinical trials.	ets	142-145	transmembrane serine protease 2	Homo sapiens	134-141	
24926821-5	2014	In TMPRSS2:ETS positive VCaP cells, depletion of TMPRSS2:ETS substantially reduced 1,25D-mediated CYP24A1 induction.	ets	11-14	transmembrane serine protease 2	Homo sapiens	3-10	
24926821-5	2014	In TMPRSS2:ETS positive VCaP cells, depletion of TMPRSS2:ETS substantially reduced 1,25D-mediated CYP24A1 induction.	ets	11-14	transmembrane serine protease 2	Homo sapiens	49-56	
24926821-5	2014	In TMPRSS2:ETS positive VCaP cells, depletion of TMPRSS2:ETS substantially reduced 1,25D-mediated CYP24A1 induction.	ets	57-60	transmembrane serine protease 2	Homo sapiens	3-10	
24926821-5	2014	In TMPRSS2:ETS positive VCaP cells, depletion of TMPRSS2:ETS substantially reduced 1,25D-mediated CYP24A1 induction.	ets	57-60	transmembrane serine protease 2	Homo sapiens	49-56	
24926821-6	2014	Artificial expression of the type VI+72 TMPRSS2:ETS isoform in LNCaP cells synergized with 1,25D to greatly increase CYP24A1 expression.	ets	48-51	transmembrane serine protease 2	Homo sapiens	40-47	
20616363-0	2010	Detection of TMPRSS2-ETS fusions by a multiprobe fluorescence in situ hybridization assay for the early diagnosis of prostate cancer: a pilot study.	ets	21-24	transmembrane serine protease 2	Homo sapiens	13-20	
19293179-3	2009	TMPRSS2-ERG, TMPRSS2-ETV1, and SLC45A3-ERG rearrangements account for roughly 90% of ETS fusion prostate cancer.	ets	85-88	transmembrane serine protease 2	Homo sapiens	0-7	
19293179-3	2009	TMPRSS2-ERG, TMPRSS2-ETV1, and SLC45A3-ERG rearrangements account for roughly 90% of ETS fusion prostate cancer.	ets	85-88	transmembrane serine protease 2	Homo sapiens	13-20